Patent · US Active

Serine protease inhibitors

US9371307B2 · kind B2 · utility

5Cited by

4References

19Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Ernesto Freire · Baltimore, US
Patrick C. Ross · College Park, US
Rogelio Siles · Baltimore, US

Key dates

Filing date	Sep 12, 2012
Grant date	Jun 21, 2016
Priority date	—
Expiry date	Nov 7, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C311/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Potent low molecular weight, highly selective, competitive non-peptidic serine protease inhibitors and their use in treating serine protease-associated diseases are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.